Yi Kathy

CIK 00016978023 companiesRICHMOND, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001697802

Recent Transactions

50 trades

Disposition to Issuer
Theseus Pharmaceuticals, Inc.
Restricted Stock Units
2024-02-14−3,250→ 0 total
Disposition to Issuer
Theseus Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-02-14−99,634→ 0 total
Award
Theseus Pharmaceuticals, Inc.
Restricted Stock Unit
2023-06-13+3,250→ 3,250 total
Award
Theseus Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-13+19,500→ 19,500 total
Award
Theseus Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-06-10+30,000→ 30,000 total
Award
Theseus Pharmaceuticals, Inc.
Stock Option (right to buy)
2021-10-06+22,678→ 22,678 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2021-02-03+216,718→ 216,718 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2020-10-28+78,534→ 78,534 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2019-05-15$10.00/sh−5,000→ 25,512 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2019-05-15$4.55/sh+5,000→ 30,512 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2019-05-15−5,000→ 125,000 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2019-04-15$4.55/sh+5,000→ 30,512 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2019-04-15$12.11/sh−5,000→ 25,512 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2019-04-15−5,000→ 130,000 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2019-03-15$4.55/sh+5,000→ 30,512 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2019-03-15$10.00/sh−5,000→ 25,512 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2019-03-15−5,000→ 135,000 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2019-03-01$10.00/sh−5,000→ 25,512 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2019-03-01$4.55/sh+5,000→ 30,512 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2019-03-01−5,000→ 140,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right-to-Buy)
2019-02-25+115,500→ 115,500 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2019-02-25+19,250→ 25,512 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2019-01-24$11.10/sh−988→ 6,262 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2019-01-15$4.55/sh+5,000→ 12,250 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2019-01-15$11.04/sh−5,000→ 7,250 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2019-01-15−5,000→ 145,000 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-12-17$4.55/sh+5,000→ 12,250 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2018-12-17−5,000→ 150,000 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-12-17$11.44/sh−5,000→ 7,250 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-11-15$4.55/sh+5,000→ 12,250 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-11-15$10.00/sh−5,000→ 7,250 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2018-11-15−5,000→ 155,000 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-10-15$4.55/sh+5,000→ 12,250 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-10-15$13.97/sh−5,000→ 7,250 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2018-10-15−5,000→ 160,000 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2018-09-17−5,000→ 165,000 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-09-17$14.66/sh−5,000→ 7,250 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-09-17$4.55/sh+5,000→ 12,250 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-08-16$4.55/sh+5,000→ 12,250 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2018-08-16−5,000→ 170,000 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-08-16$15.39/sh−5,000→ 7,250 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-07-16$4.55/sh+5,000→ 12,250 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2018-07-16−5,000→ 175,000 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-07-16$14.77/sh−5,000→ 7,250 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2018-06-15−5,000→ 180,000 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-06-15$4.55/sh+5,000→ 12,250 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-06-15$15.67/sh−5,000→ 7,250 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2018-05-15−5,000→ 185,000 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-05-15$15.38/sh−5,000→ 7,250 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-05-15$4.55/sh+5,000→ 12,250 total

Companies

Recent Filings

Address

501 CANAL BLVD POINT RICHMOND TECH CENTER

RICHMOND, CA, 94804

View on SEC.gov